Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02235545 · ClinicalTrials.gov registry record

Optisure Lead Post Approval Study

A clinical trial, sponsored by Abbott Medical Devices.

Terminated
Registry status
1,735
Enrollment target

NCT02235545 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 1,735 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02235545 was terminated before completion, sponsored by Abbott Medical Devices.

TERMINATED
Registry status
1,735 participants
Enrollment target

Study Summary

The purpose of this post approval study is to characterize the chronic performance of the SJM Optisure family of HV leads in patients.

Interventions

  • DEVICE St. Jude Medical Optisure Lead

Trial Details

FieldValue
Enrollment Target 1,735 participants
Start Date 2014-08
Est. Completion 2020-06-30

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT02235545

The ClinicalTrials.gov registry entry for NCT02235545 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,735 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which St. Jude Medical Optisure Lead is the first listed.

NCT02235545 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02235545 about?

NCT02235545 is a clinical study titled "Optisure Lead Post Approval Study". The purpose of this post approval study is to characterize the chronic performance of the SJM Optisure family of HV leads in patients.

What is the current status of trial NCT02235545?

This trial is currently terminated. The enrollment target is 1,735 participants. The study started on 2014-08. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT02235545?

The interventions under investigation include: St. Jude Medical Optisure Lead (DEVICE).

Who is sponsoring clinical trial NCT02235545?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.